PAG-led India bulk-drugs platform strikes second control deal

 PAG-led India bulk-drugs platform strikes second control deal
Hong Kong-based alternative investment firm PAG Asia Capital and its Indian consortium partners CX Partners and Samara Capital said Wednesday they have agreed to acquire a controlling stake in Hyderabad-based pharmaceutical firm Optimus Drugs Pvt Ltd. The deal marks the second acquisition by the consortium’s active pharmaceutical ingredients (APIs) platform […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.

Vivek Sinha

error: Content is protected !!
The Capital Quest